Annual Long Term Debt
$17.09 M
-$3.20 M-15.77%
31 December 2023
Summary:
Voyager Therapeutics annual long term debt is currently $17.09 million, with the most recent change of -$3.20 million (-15.77%) on 31 December 2023. During the last 3 years, it has fallen by -$21.52 million (-55.73%). VYGR annual long term debt is now -60.62% below its all-time high of $43.41 million, reached on 31 December 2020.VYGR Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$38.37 M
-$1.84 M-4.57%
30 September 2024
Summary:
Voyager Therapeutics quarterly long term debt is currently $38.37 million, with the most recent change of -$1.84 million (-4.57%) on 30 September 2024. Over the past year, it has increased by +$21.27 million (+124.47%). VYGR quarterly long term debt is now -11.61% below its all-time high of $43.41 million, reached on 31 December 2020.VYGR Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VYGR Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +124.5% |
| 3 y3 years | -55.7% | -0.6% |
| 5 y5 years | -44.8% | +23.9% |
VYGR Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -55.7% | at low | -8.6% | +124.5% |
| 5 y | 5 years | -60.6% | at low | -11.6% | +124.5% |
| alltime | all time | -60.6% | at low | -11.6% | +124.5% |
Voyager Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $38.37 M(-4.6%) |
| June 2024 | - | $40.20 M(-4.3%) |
| Mar 2024 | - | $41.99 M(+145.7%) |
| Dec 2023 | $17.09 M(-15.8%) | $17.09 M(-4.6%) |
| Sept 2023 | - | $17.92 M(-4.3%) |
| June 2023 | - | $18.73 M(-4.1%) |
| Mar 2023 | - | $19.52 M(-3.8%) |
| Dec 2022 | $20.29 M(-47.4%) | $20.29 M(-3.5%) |
| Sept 2022 | - | $21.02 M(-3.3%) |
| June 2022 | - | $21.74 M(-41.4%) |
| Mar 2022 | - | $37.12 M(-3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $38.61 M(-11.1%) | $38.61 M(-3.5%) |
| Sept 2021 | - | $40.01 M(-2.0%) |
| June 2021 | - | $40.85 M(-5.3%) |
| Mar 2021 | - | $43.14 M(-0.6%) |
| Dec 2020 | $43.41 M(+40.1%) | $43.41 M(+53.6%) |
| Sept 2020 | - | $28.26 M(-3.2%) |
| June 2020 | - | $29.18 M(-3.0%) |
| Mar 2020 | - | $30.09 M(-2.9%) |
| Dec 2019 | $30.98 M | $30.98 M(-2.6%) |
| Sept 2019 | - | $31.80 M(-2.5%) |
| June 2019 | - | $32.60 M |
FAQ
- What is Voyager Therapeutics annual long term debt?
- What is the all time high annual long term debt for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly long term debt year-on-year change?
What is Voyager Therapeutics annual long term debt?
The current annual long term debt of VYGR is $17.09 M
What is the all time high annual long term debt for Voyager Therapeutics?
Voyager Therapeutics all-time high annual long term debt is $43.41 M
What is Voyager Therapeutics quarterly long term debt?
The current quarterly long term debt of VYGR is $38.37 M
What is the all time high quarterly long term debt for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly long term debt is $43.41 M
What is Voyager Therapeutics quarterly long term debt year-on-year change?
Over the past year, VYGR quarterly long term debt has changed by +$21.27 M (+124.47%)